2BB score and signals
4D Molecular Therapeutics, Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 66 | High |
| Momentum | 55 | Stable |
| Financial strength | 41 | Normal |
| Quality | 98 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Emeryville, California, United States |
| Founded | 2013 |
| Employees | 196 |
| 52-week range | $6.96 – $16.91 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-16 | — | -1.0659 | — | $3.18M |
| 2026-11-09 | — | -1.0659 | — | $2.49M |
| 2026-08-10 | — | -1.037 | — | $3.16M |
| 2026-05-07 | -1.01 | -1.0121 | $3.05M | $5.27M |
Related companies
2BBBullish & Bearish